LPNs were designed for targeted delivery of RSV and DTX to the mitochondria of tumor cells by conjugating the epidermal growth factor (EGF) and stearic acid (SA) with polyethylene glycol (PEG). The gene discussed is EGF; the disease is neoplasm.